Gregor Hasler
Overview
Explore the profile of Gregor Hasler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
137
Citations
4231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Greil W, de Bardeci M, Nievergelt N, Erfurth A, Hasler G, Bridler R, et al.
Int J Bipolar Disord
. 2025 Feb;
13(1):3.
PMID: 39945975
Background: Global pharmacoepidemiological evidence suggests dynamically changing prescription patterns in patients with bipolar disorders. We assessed trends in the use of pharmacological agents used in the management of bipolar disorders...
2.
Calder A, Qualls C, Hasler G, Elmiger D, Strassman R
Biol Psychiatry Glob Open Sci
. 2025 Feb;
5(2):100436.
PMID: 39926700
Background: The Hallucinogen Rating Scale (HRS) has been widely used to measure the subjective effects of psychedelics and other psychoactive substances. Its advantages include a basis in phenomenological interviews and...
3.
Calder A, Hase A, Hasler G
Mol Psychiatry
. 2024 Nov;
30(2):763-776.
PMID: 39613915
Background: Peripheral levels of brain-derived neurotrophic factor (BDNF) are often used as a biomarker for the rapid plasticity-promoting effects of ketamine, psychedelics, and other psychoplastogens in humans. However, studies analyzing...
4.
Solmi M, Thompson T, Cortese S, Estrade A, Agorastos A, Radua J, et al.
J Am Acad Child Adolesc Psychiatry
. 2024 Nov;
PMID: 39581373
Objective: To identify the COVID-19 pandemic impact on well-being/mental health, coping strategies, and risk factors in adolescents worldwide. Method: This study was based on an anonymous online multi-national/multi-language survey in...
5.
Kupferberg A, Hasler G
Front Psychiatry
. 2024 Oct;
15:1372650.
PMID: 39469469
Social cognitive deficits and social behavior impairments are common in major depressive disorder (MDD) and affect the quality of life and recovery of patients. This review summarizes the impact of...
6.
Solmi M, Thompson T, Cortese S, Estrade A, Agorastos A, Radua J, et al.
Eur Neuropsychopharmacol
. 2024 Sep;
90:1-15.
PMID: 39341043
There is no multi-country/multi-language study testing a-priori multivariable associations between non-modifiable/modifiable factors and validated wellbeing/multidimensional mental health outcomes before/during the COVID-19 pandemic. Moreover, studies during COVID-19 pandemic generally do not...
7.
Solmi M, Thompson T, Estrade A, Agorastos A, Radua J, Cortese S, et al.
Psychiatry Res
. 2024 Sep;
342:115972.
PMID: 39305825
International studies measuring wellbeing/multidimensional mental health before/ during the COVID-19 pandemic, including representative samples for >2 years, identifying risk groups and coping strategies are lacking. COH-FIT is an online, international,...
8.
Calder A, Rausch B, Liechti M, Holze F, Hasler G
J Psychopharmacol
. 2024 Sep;
38(10):873-886.
PMID: 39302087
Background: Psychedelic-assisted therapy (PAT) is permitted in Switzerland under its limited medical use program. Data from patients in this program represent a unique opportunity to analyze the real-world practice of...
9.
Calder A, Hasler G
J Affect Disord
. 2024 Aug;
365:258-264.
PMID: 39168165
Introduction: Studies of psychedelic-assisted therapy with LSD, psilocybin, MDMA, and related substances show clinical promise but inadequately assess side effects. Measuring side effects is challenging because they are not always...
10.
Hasler G, Inta D
Psychother Psychosom
. 2024 Aug;
93(5):285-291.
PMID: 39154647
Neuroprotection aims to safeguard neurons from damage caused by various factors like stress, potentially leading to the rescue, recovery, or regeneration of the nervous system and its functions [J Clin...